日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/15 | 1,901 | 1,901 | 1,889 | 1,889 | -7 | -0.4% | 3,100 |
| 2022/06/14 | 1,903 | 1,919 | 1,896 | 1,896 | -7 | -0.4% | 1,800 |
| 2022/06/13 | 1,906 | 1,920 | 1,900 | 1,903 | -7 | -0.4% | 3,400 |
| 2022/06/10 | 1,912 | 1,924 | 1,910 | 1,910 | -14 | -0.7% | 3,200 |
| 2022/06/09 | 1,915 | 1,932 | 1,911 | 1,924 | +6 | +0.3% | 2,900 |
| 2022/06/08 | 1,935 | 1,935 | 1,915 | 1,918 | -5 | -0.3% | 1,700 |
| 2022/06/07 | 1,913 | 1,928 | 1,913 | 1,923 | +10 | +0.5% | 2,000 |
| 2022/06/06 | 1,938 | 1,940 | 1,913 | 1,913 | -27 | -1.4% | 3,800 |
| 2022/06/03 | 1,926 | 1,942 | 1,920 | 1,940 | +13 | +0.7% | 2,600 |
| 2022/06/02 | 1,940 | 1,943 | 1,919 | 1,927 | -2 | -0.1% | 4,700 |
| 2022/06/01 | 1,956 | 1,956 | 1,915 | 1,929 | +13 | +0.7% | 3,100 |
| 2022/05/31 | 1,920 | 1,926 | 1,910 | 1,916 | -4 | -0.2% | 5,100 |
| 2022/05/30 | 1,952 | 1,952 | 1,909 | 1,920 | -31 | -1.6% | 20,700 |
| 2022/05/27 | 2,119 | 2,298 | 1,951 | 1,951 | +51 | +2.7% | 127,100 |
| 2022/05/26 | 1,906 | 1,911 | 1,900 | 1,900 | -6 | -0.3% | 2,700 |
| 2022/05/25 | 1,906 | 1,918 | 1,906 | 1,906 | ±0 | ±0% | 1,300 |
| 2022/05/24 | 1,921 | 1,921 | 1,906 | 1,906 | -24 | -1.2% | 2,000 |
| 2022/05/23 | 1,922 | 1,935 | 1,920 | 1,930 | +7 | +0.4% | 1,000 |
| 2022/05/20 | 1,916 | 1,923 | 1,914 | 1,923 | +3 | +0.2% | 1,000 |
| 2022/05/19 | 1,916 | 1,925 | 1,916 | 1,920 | -13 | -0.7% | 700 |
| 2022/05/18 | 1,937 | 1,937 | 1,922 | 1,933 | -5 | -0.3% | 2,600 |
| 2022/05/17 | 1,940 | 1,944 | 1,930 | 1,938 | +25 | +1.3% | 2,500 |
| 2022/05/16 | 1,925 | 1,944 | 1,900 | 1,913 | -3 | -0.2% | 4,400 |
| 2022/05/13 | 1,909 | 1,947 | 1,905 | 1,916 | +7 | +0.4% | 2,100 |
| 2022/05/12 | 1,911 | 1,941 | 1,907 | 1,909 | -2 | -0.1% | 1,600 |
| 2022/05/11 | 1,921 | 1,937 | 1,911 | 1,911 | -10 | -0.5% | 2,700 |
| 2022/05/10 | 1,930 | 1,942 | 1,921 | 1,921 | -9 | -0.5% | 2,200 |
| 2022/05/09 | 1,953 | 1,953 | 1,930 | 1,930 | -12 | -0.6% | 4,200 |
| 2022/05/06 | 1,950 | 1,953 | 1,942 | 1,942 | -5 | -0.3% | 2,800 |
| 2022/05/02 | 1,950 | 1,955 | 1,946 | 1,947 | -3 | -0.2% | 4,300 |
| 2022/04/28 | 1,953 | 1,956 | 1,950 | 1,950 | -3 | -0.2% | 2,800 |
| 2022/04/27 | 1,962 | 1,977 | 1,953 | 1,953 | -10 | -0.5% | 5,100 |
| 2022/04/26 | 1,965 | 1,976 | 1,961 | 1,963 | -5 | -0.3% | 3,000 |
| 2022/04/25 | 1,990 | 1,990 | 1,964 | 1,968 | -22 | -1.1% | 3,800 |
| 2022/04/22 | 1,997 | 1,997 | 1,978 | 1,990 | +12 | +0.6% | 2,200 |
| 2022/04/21 | 1,973 | 1,978 | 1,973 | 1,978 | -7 | -0.4% | 1,500 |
| 2022/04/20 | 1,981 | 1,985 | 1,971 | 1,985 | ±0 | ±0% | 2,100 |
| 2022/04/19 | 1,990 | 1,992 | 1,970 | 1,985 | -13 | -0.7% | 3,300 |
| 2022/04/18 | 2,000 | 2,000 | 1,989 | 1,998 | -2 | -0.1% | 1,400 |
| 2022/04/15 | 2,001 | 2,001 | 2,000 | 2,000 | -3 | -0.1% | 1,700 |
| 2022/04/14 | 1,999 | 2,030 | 1,999 | 2,003 | +4 | +0.2% | 800 |
| 2022/04/13 | 1,990 | 2,004 | 1,990 | 1,999 | +9 | +0.5% | 3,300 |
| 2022/04/12 | 1,990 | 2,000 | 1,987 | 1,990 | -9 | -0.5% | 2,200 |
| 2022/04/11 | 2,002 | 2,007 | 1,999 | 1,999 | -12 | -0.6% | 4,600 |
| 2022/04/08 | 2,010 | 2,017 | 2,001 | 2,011 | -6 | -0.3% | 2,300 |
| 2022/04/07 | 2,019 | 2,021 | 2,001 | 2,017 | -10 | -0.5% | 2,500 |
| 2022/04/06 | 2,051 | 2,051 | 2,027 | 2,027 | -41 | -2% | 4,700 |
| 2022/04/05 | 2,057 | 2,068 | 2,050 | 2,068 | +4 | +0.2% | 2,600 |
| 2022/04/04 | 2,092 | 2,092 | 2,048 | 2,064 | -34 | -1.6% | 1,800 |
| 2022/04/01 | 2,084 | 2,099 | 2,084 | 2,098 | +14 | +0.7% | 1,300 |
601～
650
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ティムス | 20,500円 | - | - | 0.00% | - | 2.78倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
| ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
